文献速递血栓与止血贫血与红细胞疾病

镰状细胞病女性妊娠相关血栓栓塞:美国国家医疗补助数据分析

Pregnancy-related thromboembolism in women with sickle cell disease: An analysis of National Medicaid Data.
PubMed 文献 · Am J Hematol · 2023-08-08

基于美国2006至2018年医疗补助行政索赔数据,比较镰状细胞病(SCD)孕妇与非SCD孕妇的妊娠相关血栓栓塞风险。SCD组6388例、对照组17110例,SCD组静脉血栓栓塞11.3%、动脉血栓栓塞5.2%,对照组分别为1.2%和0.6%,SCD组血栓栓塞风险约为对照组的8至11倍(p<.001)。

要点

  • SCD孕妇静脉血栓栓塞发生率为11.3%,对照组为1.2%;动脉血栓栓塞为5.2%对0.6%。
  • SCD孕妇血栓栓塞风险约为无SCD孕妇的8至11倍(p<.001)。
  • SCD组内年龄、HbSS基因型、高血压和血栓史为妊娠相关血栓栓塞的独立危险因素。

核心结论

  • SCD患者妊娠相关血栓栓塞风险显著高于无SCD的对照人群。
  • 作者认为SCD患者,尤其存在多重危险因素者,可能是妊娠期及产后血栓预防的候选人群。

研究设计与样本

  • 使用美国Centers for Medicare and Medicaid Service Analytic eXtract 2006至2018年行政索赔数据。
  • 研究人群为SCD患者从首次识别妊娠开始至产后1年,并设年龄和种族相似的无SCD孕妇对照队列。
  • 共识别6388例SCD患者和17110例对照的分娩记录,结局采用ICD-9或ICD-10编码识别,采用逻辑回归分析危险因素。

主要发现

  • SCD组观察到720例静脉血栓栓塞(11.3%)和335例动脉血栓栓塞(5.2%),对照组分别为202例(1.2%)和95例(0.6%)。
  • SCD组血栓栓塞的比值比约为对照组的8至11倍(p<.001)。
  • SCD队列内,年龄、血红蛋白SS(HbSS)基因型、高血压和血栓史被确定为妊娠相关血栓栓塞的独立危险因素。
  • 妊娠特异性因素(子痫前期、子痫、多胎妊娠)与血栓栓塞无关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pregnancy and sickle cell disease (SCD) both individually carry a risk of thromboembolism (TE). Pregnancy in people with SCD may further enhance the prothrombotic effect of the underlying disease. The objectives of this study were to determine the rate and risk factors for arterial and venous thrombosis in pregnant people with SCD. Administrative claims data from the United States Centers for Medicare and Medicaid Service Analytic eXtract from 2006 to 2018 were used. The study population included people with SCD from the start of their first identified pregnancy until 1 year postpartum and a control cohort of pregnant people without SCD of similar age and race. Outcomes of interest were identified with ICD-9 or 10 codes. Logistic regression analyses were used to analyze risk factors. We identified infant deliveries in 6388 unique people with SCD and 17 110 controls. A total of 720 venous thromboembolism (11.3%) and 335 arterial TE (5.2%) were observed in people with SCD compared to 202 (1.2%) and 95 (0.6%) in controls. People with SCD had an 8-11 times higher odds of TE compared to controls (p < .001). Within the SCD cohort, age, hemoglobin SS (HbSS) genotype, hypertension, and history of thrombosis were identified as independent risk factors for pregnancy-related TE. Pregnancy-specific factors (pre-eclampsia, eclampsia, multigestational pregnancy) were not associated with TE. In conclusion, the risk of pregnancy-related TE is considerably higher in people with SCD compared with controls without SCD. Hence, people with SCD, particularly those with multiple risk factors may be candidates for thromboprophylaxis during pregnancy and the postpartum period.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Agarwal S, Stanek JR, Vesely SK, et al. Pregnancy-related thromboembolism in women with sickle cell disease: An analysis of National Medicaid Data. Am J Hematol. 2023. PMID: 37551881. doi:10.1002/ajh.27045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。